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Actinomycetes are known for their unprecedented ability to produce novel lead compounds of clinical and pharmaceutical importance ([@B1][@B2][@B4]). Among the many actinobacterial genera, *Streptomyces*, *Micromonospora*, *Nocardiopsis*, and *Rhodococcus* are the most prolific producers of secondary metabolites, which display broad chemical diversity and diverse pharmaceutically and medically relevant bioactivities ([@B5][@B6][@B8]). Recent genomic sequencing data have revealed the presence of a plethora of putative biosynthetic gene clusters on the genomes of actinomycetes encoding for secondary metabolites that are not observed under standard fermentation conditions ([@B9][@B10][@B13]). In the present study, draft genomes of three actinobacterial isolates, *Micromonospora* sp. RV43, *Rubrobacter* sp. RV113, and *Nocardiopsis* sp. RV163 that had previously been cultivated from the Mediterranean sponges *Aplysina aerophoba* (RV43 and RV113) and *Dysidea avara* (RV163) ([@B14]), were established.

The genomic DNA of the isolates was extracted from 5-day-old ISP2 cultures. Paired-end, 2 × 250-bp libraries were prepared with the Nextera XT kit (Illumina, Inc.). Sequencing was performed on an Illumina MiSeq device. A total of 5,900,702 raw reads were produced for *Micromonospora* sp. RV43, 2,206,732 raw reads for *Rubrobacter* sp. RV113 and 4,851,980 raw reads were delivered for *Nocardiopsis* sp. RV163. Reads were adapter clipped, quality trimmed and length filtered ([@B15]). Initial contigs were generated using SPAdes ([@B16]) and only contigs ≥1000 bp were maintained. A further clean-up of contigs was performed using G+C-content, coverage, and taxonomic assignments ([@B17]). For *ab initio* gene prediction, prodigal was applied ([@B18]) and functional annotation of the predicted protein sequences was performed with the RAST webserver ([@B19]). Secondary metabolite gene clusters and possible encoded compounds were predicted with antiSMASH ([@B20]) and NapDos ([@B21]).

A number of 101 (RV43), 33 (RV113), and 82 (RV163) secondary metabolite gene clusters were detected with antiSMASH. For strain RV43, 5 terpene clusters, 4 type 1 PKS clusters, 2 lantipeptides, 1 type 2 PKS cluster, 1 siderophore, 1 NRPS cluster, and 1 bacteriocin were found. For strain RV113, 3 terpene clusters, 1 fatty acid, and 1 mixed type 3 PKS-fatty acid cluster were found. The draft genome sequence of strain RV163 showed homologies to 7 NRPS clusters, 4 terpene gene clusters, 2 type 1 PKS clusters, 2 ectoines, 2 bacteriocins, 1 phenanzine, 1 butyrolacetone, 1 type 2 PKS, and 1 siderophore.

For *Micromonospora* sp. RV43, NaPDoS predicted the presence of gene clusters encoding for compounds such as leinamycin, kirromycin, aclacinomycin, and tetronomycin. For *Nocardiopsis* sp. RV163, compounds such as alnumycin, avermectin, and neocarzinostatin were predicted. For *Rubrobacter* sp. RV113, only gene clusters encoding for fatty acids synthesis were found. These results highlight the genomic potential of at least two of three inspected isolates for natural products discovery.
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